09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 1.<br />

Experimental design for carcinogenicity bioassay of cupferron using male and female<br />

Fischer 344 (F344) rats and B6C3F 1 mice (NCI, 1978)<br />

Sex/species Group Cupferron<br />

concentration<br />

(%)<br />

Experiment duration<br />

(weeks)<br />

Time-weighted<br />

average<br />

concentration 1<br />

treatment<br />

period<br />

observation<br />

period<br />

male rats control 0 0 110<br />

low dose 0.15 78 26<br />

high dose 0.3 78 19<br />

female rats control 0 0 110<br />

low dose 0.15 78 28<br />

high dose 0.3 78 28<br />

male, female mice control 0 98 0<br />

low dose 0.3 35 0.2<br />

0.1 43 18<br />

high dose 0.6 35 0.4<br />

0.2 43 17<br />

1. Time-weighted concentration = ∑ (concentration × weeks received )<br />

∑ (weeks receiving chemical)<br />

Table 2.<br />

Cupferron-induced hemangiosarcoma incidence in male and female F344 rats and<br />

B6C3F 1 mice (NCI, 1978)<br />

Sex/species Dose group Average dose 1<br />

(mg/kg-day)<br />

Tumor incidence 2<br />

Male rat control 0 0/50<br />

low dose 45 38/50<br />

high dose 96.5 35/49<br />

Female rat control 0 0/50<br />

low dose 55.2 28/50<br />

high dose 110 37/50<br />

Male mouse control 0 1/50<br />

low dose 185 3/50<br />

high dose 374 7/50<br />

Female mouse control 0 1/50<br />

low dose 200 5/50<br />

high dose 405 6/50<br />

226

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!